๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
This phase I trial studies the best dose and side effects of NY-ESO-1 T cel...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2019-03-08
Trial ID
NCT03691376
Treatments Being Tested
Epstein-Barr virus (EBV) DNAemia is a common and potentially serious compli...
Status
Recruiting
Location
Chinese PLA General Hospital
Start Date
2025-06-01
Trial ID
NCT07368634
Treatments Being Tested
This phase 2 study aims to confirm the efficacy observed in the prior phase...
Status
Recruiting
Location
Washington University
Start Date
2024-09-23
Trial ID
NCT06529731
Treatments Being Tested
This is a phase I/II protocol to evaluate the safety and efficacy of ADA ge...
Status
Completed
Location
Investigational Site
Start Date
2002-10-02
Trial ID
NCT00598481
Treatments Being Tested
This phase I trial studies the side effects of NY-ESO-1 TCR engineered peri...
Status
Withdrawn
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2018-07-10
Trial ID
NCT03506802
This clinical trial will access the toxicity and efficacy of infusion of ge...
Status
Terminated
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2012-02-22
Trial ID
NCT01331018
The Investigators propose to test the hypothesis that GCSF therapy enhances...
Status
Completed
Location
Children's National Medical Center
Start Date
2018-01-15
Trial ID
NCT03395028
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of genetically...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2011-09-19
Trial ID
NCT01318317
This phase II trials studies the effects of yttrium-90 labeled anti-CD25 mo...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2021-11-02
Trial ID
NCT04871607